AVOLVE Trademark

Trademark Overview


On Tuesday, June 11, 2002, a trademark application was filed for AVOLVE with the United States Patent and Trademark Office. The USPTO has given the AVOLVE trademark a serial number of 78134751. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, November 26, 2006. This trademark is owned by Glaxo Group Limited. The AVOLVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity and for the treatment of metabolic musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations.

General Information


Serial Number78134751
Word MarkAVOLVE
Filing DateTuesday, June 11, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, November 26, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 2, 2003

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity and for the treatment of metabolic musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 20, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Trademark Events


Event DateEvent Description
Wednesday, January 31, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, January 31, 2007ABANDONMENT - NO USE STATEMENT FILED
Friday, November 10, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 23, 2006EXTENSION 5 GRANTED
Tuesday, May 23, 2006EXTENSION 5 FILED
Tuesday, May 23, 2006TEAS EXTENSION RECEIVED
Tuesday, May 23, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 23, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 3, 2005EXTENSION 4 GRANTED
Thursday, November 3, 2005EXTENSION 4 FILED
Thursday, November 3, 2005TEAS EXTENSION RECEIVED
Monday, May 9, 2005EXTENSION 3 GRANTED
Tuesday, April 19, 2005EXTENSION 3 FILED
Tuesday, April 19, 2005TEAS EXTENSION RECEIVED
Thursday, October 14, 2004EXTENSION 2 GRANTED
Thursday, October 14, 2004EXTENSION 2 FILED
Thursday, October 14, 2004TEAS EXTENSION RECEIVED
Thursday, October 14, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 25, 2004CASE FILE IN TICRS
Tuesday, January 20, 2004EXTENSION 1 GRANTED
Tuesday, January 20, 2004EXTENSION 1 FILED
Tuesday, January 20, 2004TEAS EXTENSION RECEIVED
Tuesday, November 25, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 2, 2003PUBLISHED FOR OPPOSITION
Wednesday, August 13, 2003NOTICE OF PUBLICATION
Monday, June 30, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 14, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2003PAPER RECEIVED
Thursday, October 17, 2002NON-FINAL ACTION MAILED
Thursday, October 3, 2002ASSIGNED TO EXAMINER